Mutation's Role in Region-Specific Pediatric Brain Tumors Revealed

St. Jude Children's Research Hospital scientists have demonstrated how the H3.3 K27M mutation differentially affects brain cells based on their location, driving diffuse midline glioma (DMG). Published in Nature Communications, the study explains why this pediatric brain cancer, currently without effective treatments, primarily arises in the brainstem and midline regions. The mutation keeps brainstem cells in an immature, dividing state, increasing DMG susceptibility.